News

NaviMed-backed Citrus Health Group Launches

Industry veterans join forces to launch scientific, medical communications and market access platform

ClariMed, Inc. Launches Integrated Medical Device Services Partner

New NaviMed Portfolio Company Attracts Top Medical Products & Services Executive and Acquires Leading Human Factors Provider

NaviMed Portfolio Company The CM Group to be Acquired by OPEN Health

NaviMed Portfolio Company CenterPointe Behavioral Health System Acquired by Acadia Healthcare

NaviMed’s Lighthouse Lab Services Announces a Majority Growth Recapitalization

NaviMed Portfolio Company Argos Health Acquired

NaviMed Capital Closes Fund II at $290 Million

Firm Remains Focused on Partnering with Healthcare Business Owners on Control Growth Transactions

NaviMed Portfolio Company Velocity Clinical Research Acquired

NaviMed Capital Announces Expansion of Investment and Operations Teams

Firm adds two experienced investment professionals and CFO/CCO.

COVID-19 Vaccine Trial Starts Recruiting Patients, Including at Velocity Sites

Velocity Clinical Research is one of the companies conducting the clinical trials

Argos Health Named Black Book’s Top Complex Claims Solutions Vendor for 2020

For the second year in a row, Argos Health has been named the number one Complex Claims vendor by Black Book Research.

Velocity Clinical Acquires Additional Clinical Trial Sites and Adds a Vaccine-study Strategic Partnership

Velocity acquires two new clinical trial sites in Indiana and Rhode Island

Global Healthcare Exchange Announces Acquisition of Lumere

Bijan Salehizadeh served as a board member of Lumere

Argos Health Rated Highest in Client Satisfaction for Complex Claims Solutions, 2019 Black Book Healthcare CFO Survey

Survey of 484 hospitals and inpatient organizations selects top client-rated software and services vendors

Argos Health Announces the Acquisition of Caid Solutions

Transaction adds out-of-state Medicaid complex claim services to Argos Health’s offerings

Johnson & Johnson Announces Agreement to Acquire Auris Health

Johnson & Johnson Announces Agreement to Acquire Auris Health for up to $5.8 billion. Bijan Salehizadeh served as a board member of Auris since inception.

Durham-based Velocity Clinical Purchases Clinical Research Sites

CenterPointe Hospital St. Louis, a division of CenterPointe Behavioral Health System, names new CEO

CenterPointe Hospital, based in St. Louis, MO, has hired Scott Williams as new hospital CEO.

Signature Psychiatric, a division of CenterPointe Behavioral Health System, doubles beds in KC market with expansion in Northland

Signature Psychiatric, a division of CenterPointe Behavioral Health System, doubles beds in KC market with expansion in Northland

Formation of Argos Health Gives Healthcare Providers New RCM Outsourcing Option

Introducing the New National Provider of Complex Claims Resolution

Lucent Health Solutions acquires Cypress Benefit Administrators

Lucent Health strengthens its market presence in the Midwest, Pacific Northwest and Rocky Mountain regions through acquisition.

Construction on New CenterPointe Columbia, MO Psychiatric Hospital Set to Begin

A groundbreaking ceremony was held for CenterPointe's new 72-bed mental health facility in Columbia, MO. The hospital will provide psychiatric and substance abuse treatment for people of all ages in the mid-Missouri region.

CenterPointe Behavioral Health System Receives State Approval for 72 bed Expansion in Columbia, MO

CenterPointe Hospital’s proposal for a 72-bed psychiatric hospital in Columbia, MO received unanimous support from the State Health Facilities Review Committee

NaviMed Capital Announces Addition of Experienced Senior Advisor and Expansion of Investment Team

NaviMed Capital announced the expansion of its team with the addition of an experienced hospital executive as a Senior Advisor to the firm and the recent hiring of two investment Associates.

CenterPointe Behavioral Health System Announces Significant Growth Capital Investment

CenterPointe Behavioral Health System, LLC (CBHS) announced today a control growth capital investment co-led by a syndicate of investors including Health Enterprise Partners and NaviMed Capital, with participation by Siguler Guff & Company, LP.